Pay to Marwadi

Company Profile

INDO US BIO-TECH LTD.

NSE : NABSE : 541304ISIN CODE : INE250Z01010Industry : AgricultureHouse : Private
BSE235.0018.95 (+8.77 % )
PREV CLOSE (Rs.) 216.05
OPEN PRICE (Rs.) 235.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 500
TODAY'S LOW / HIGH (Rs.)235.00 235.00
52 WK LOW / HIGH (Rs.) 90.1 303.95
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 1.175
Dividend Yield(%)
TTM EPS (Rs.)
P/E Ratio
Book Value (Rs.)
Face Value (Rs.)
MCap (Rs. in Mn)
Price/Earning (TTM)
Price/Sales (TTM)
Price/Book (MRQ)
PAT Margin (%) 11.73
ROCE (%) 14.62
Incorporation Year : 2004

Management Info :

- Chairman Jagdish Ajudia - Managing Director

Registered Office :

Address : 309, Shanti Mall, Satadhar Char Rasta,Opp. Navrang Tower,Sola Road ,
Ahmedabad,
Gujarat-380061

Phone : 079 2749 1807 / 9909043999

Registrar's Details : Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE
NEWS More
24Apr04-24-2024$Indo Us Bio-Tech informs about disclosure Indo Us Bio-Tech informs abo
Indo Us Bio-Tech has informed that the Company does not fulfill any of the criteria of ‘Large Corporate’, as per the framework provided in the SEBI Circular and hence does not fall in the category of ‘Large Corporate’ as defined under SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018.

The above information is a part of company’s filings submitted to BSE.

Indo Us Bio-Tech has informed that the Company does not fulfill..
19Apr04-19-2024$ Announcement Under Regulation 30- Clarification Letter For Clerical And Typographical Error In Annual Report For The Year 2022-23 Announcement Under Regulati
With reference to captioned subject we would like to draw your attention that in the Annual Report of 2022-23 the figure was wrongly mentioned and hence we have updated the same. Further we would like to inform that it was clerical error which was unintentional and not deliberate. Moreover it do not have any imapct on profitability of the Company.
With reference to captioned subject we would like to draw your..
04Apr04-04-2024$ Clarification sought from Indo Us Bio-Tech Ltd Clarification sought from I
The Exchange has sought clarification from Indo Us Bio-Tech Ltd on April 4, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded. The reply is awaited.
The Exchange has sought clarification from Indo Us Bio-Tech Ltd..
11Jan01-11-2024$Indo Us Bio-Tech informs about compliances-certificate Indo Us Bio-Tech informs abo
Indo Us Bio-Tech has enclosed a Certificate dated 08th Day of January, 2024 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on 31 December, 2023 received from Bigshare Services, Registrar and Share Transfer Agent of the company.

The above information is a part of company’s filings submitted to BSE.

Indo Us Bio-Tech has enclosed a Certificate dated 08th Day of J..
24Aug08-24-2023$Indo US Bio Tech enters into RCO with Chhattisgarh State Seed and Agriculture Development Corporation Indo US Bio Tech enters into

Indo US Bio-Tech has entered into a Rate Contract (RCO) with Chhattisgarh State Seed and Agriculture Development Corporation for Supply of Hybrid Vegetable Seeds. The Company has entered into a RCO on August 22, 2023. This RCO signifies a significant collaboration that aligns with its business objectives.

Indo US Bio-Tech is engaged in multi-disciplinary crop improvement research programmes.

Indo US Bio-Tech has entered into a Rate Contract (RCO) with Ch..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit36.8572.4
Gross Profit 37.54 73.87
Operating Profit 43.1793.97
Net Sales 221.14617.45
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Kaveri Seed (BSE)
 879.75 (5.36%)
M.Cap ( in Cr)
4525.35
Venkys India (BSE)
 1803.60 (0.85%)
M.Cap ( in Cr)
2540.79
Nath Bio-Genes (BSE)
 207.20 (3.83%)
M.Cap ( in Cr)
393.76
JK Agri Genetics (BSE)
 409.00 (1.65%)
M.Cap ( in Cr)
189.65
Simran Farms (BSE)
 133.10 (1.99%)
M.Cap ( in Cr)
50.47
Shareholding Pattern More
PROMOTERS 70.17 %
NON-INSTITUTION 29.83 %
MUTUAL FUNDS/UTI 0 %
FI/BANKS/INSURANCE 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS
Scheme NameHold(%)
No Data Found
F & O Quotes